ICUIICU Medical, Inc.

$179.43

The financials

ICU Medical, Inc. by the numbers

ICU Medical, Inc. (ICUI) reported revenue of $530M in Q1 2026 (quarter ended March 31, 2026), down 12% from the same quarter a year earlier. That came with a gross margin of 39% and net income of $30M (5.7% of revenue). For the full year FY2025, revenue was $2.23B (−6.3% year on year) and net income $732K. Its largest region in 2026-Q1 was US at $316M, 60% of the disclosed total, just ahead of EMEA at 20%.

ICU Medical, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$530M$605M−12%
Gross profit$206M$210M−1.8%
Operating income$14M$13M+5.4%
Net income$30M−$15Mto a profit
Diluted EPS$1.20−$0.63to a profit
Revenue by region, 2026-Q1, as reported to the SEC
GeographicRevenueShare
US$316M60%
EMEA$105M20%
Asia Pacific$58M11%
Otherforeigncountries$52M9.8%

Business Segments

Revenue split by geographic segment, from SEC XBRL filings.

Latest period: Q1 2026Total $530.2M (-1.3%)
EMEA grew +9.4% year on yearUS -19% year on year
  • US$315.5MQoQ +2.7%year on year -19%
  • EMEA$104.7MQoQ -9.1%year on year +9.4%
  • Asia Pacific$58.3MQoQ +1.4%year on year -1.9%
  • Otherforeigncountries$51.7MQoQ -9.7%year on year -16%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-05-07, SEC EDGAR